YU58600A - Oblik vi 5,6-dihloro-2-(izopropilamino)-1-(beta-l-ribofuranozil)-1h-benzimidazola - Google Patents

Oblik vi 5,6-dihloro-2-(izopropilamino)-1-(beta-l-ribofuranozil)-1h-benzimidazola

Info

Publication number
YU58600A
YU58600A YU58600A YU58600A YU58600A YU 58600 A YU58600 A YU 58600A YU 58600 A YU58600 A YU 58600A YU 58600 A YU58600 A YU 58600A YU 58600 A YU58600 A YU 58600A
Authority
YU
Yugoslavia
Prior art keywords
ribofuranosyl
isopropylamino
benzimidazole
dichloro
beta
Prior art date
Application number
YU58600A
Other languages
English (en)
Inventor
Howard Barry Carter
Anne Hodgson
Lian-Fneg Huang
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of YU58600A publication Critical patent/YU58600A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Abstract

Ovaj pronalazak se odnosi na Oblik VI 5,6-dihloro-2-(izopropilamino)-1-b-L-ribofuranozil-1H-benzimidazola, na farmaceutske preparate i njihovu upotrebu u medicinskoj terapiji.[The invention relates to Form VI 5,6-dichloro-2-(isopropylamino)-1-Гџ-L-ribofuranosyl-1H-benzimidazole, pharmaceutical compositions, and their use in medical therapy.
YU58600A 1998-04-07 1999-04-01 Oblik vi 5,6-dihloro-2-(izopropilamino)-1-(beta-l-ribofuranozil)-1h-benzimidazola YU58600A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9807355.4A GB9807355D0 (en) 1998-04-07 1998-04-07 Antiviral compound

Publications (1)

Publication Number Publication Date
YU58600A true YU58600A (sh) 2003-04-30

Family

ID=10829933

Family Applications (1)

Application Number Title Priority Date Filing Date
YU58600A YU58600A (sh) 1998-04-07 1999-04-01 Oblik vi 5,6-dihloro-2-(izopropilamino)-1-(beta-l-ribofuranozil)-1h-benzimidazola

Country Status (40)

Country Link
US (1) US6482939B1 (sh)
EP (1) EP1070078B1 (sh)
JP (1) JP2002510702A (sh)
KR (1) KR100573635B1 (sh)
CN (1) CN1222534C (sh)
AP (1) AP2000001946A0 (sh)
AR (1) AR014973A1 (sh)
AT (1) ATE231517T1 (sh)
AU (1) AU753527B2 (sh)
BG (1) BG104909A (sh)
BR (2) BR9909471A (sh)
CA (1) CA2327495C (sh)
CO (1) CO5011057A1 (sh)
DE (1) DE69905025T2 (sh)
DK (1) DK1070078T3 (sh)
EA (1) EA002953B1 (sh)
EE (1) EE04121B1 (sh)
EG (1) EG24597A (sh)
ES (1) ES2191429T3 (sh)
GB (1) GB9807355D0 (sh)
GE (1) GEP20022840B (sh)
HK (1) HK1032060A1 (sh)
HR (1) HRP20000670B1 (sh)
HU (1) HUP0101549A3 (sh)
ID (1) ID26573A (sh)
IL (2) IL138559A0 (sh)
IS (1) IS5634A (sh)
MA (1) MA26617A1 (sh)
NO (1) NO316896B1 (sh)
NZ (1) NZ507012A (sh)
OA (1) OA11534A (sh)
PE (1) PE20000356A1 (sh)
PL (1) PL194752B1 (sh)
PT (1) PT1070078E (sh)
SI (1) SI1070078T1 (sh)
SK (1) SK283735B6 (sh)
TR (1) TR200002847T2 (sh)
WO (1) WO1999051617A2 (sh)
YU (1) YU58600A (sh)
ZA (1) ZA200005197B (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB0008939D0 (en) * 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
EP2265115B1 (en) * 2008-03-12 2012-11-28 Janssen Pharmaceutica, N.V. Combinations of hydroxypyrion compounds and silver compounds
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
US8541391B2 (en) * 2010-10-28 2013-09-24 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
US8940707B2 (en) 2010-10-28 2015-01-27 Viropharma Incorporated Maribavir isomers, compositions, methods of making and methods of using
WO2023105483A1 (en) * 2021-12-10 2023-06-15 Assembly Biosciences, Inc. Crystalline forms of a 5-aminopyrazole compound useful for treating hbv
WO2024081308A1 (en) 2022-10-12 2024-04-18 Takeda Pharmaceutical Company Limited Method of preparing maribavir

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3399987A (en) 1965-08-02 1968-09-03 United States Borax Chem 2-alkylaminobenzimidazoles as herbicides
CH443777A (de) 1965-08-06 1968-02-15 Agripat Sa Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
US3655901A (en) 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
SE9003151D0 (sv) 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
WO1994008456A1 (en) 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
GB9600143D0 (en) 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
GB2319961A (en) * 1996-12-07 1998-06-10 Glaxo Group Ltd Pharmaceutical composition for treatment of restenosis
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound

Also Published As

Publication number Publication date
SI1070078T1 (en) 2003-08-31
CA2327495C (en) 2009-01-20
HRP20000670B1 (en) 2004-04-30
NO20005003D0 (no) 2000-10-04
DE69905025T2 (de) 2003-10-16
AU753527B2 (en) 2002-10-17
EA200000909A1 (ru) 2001-06-25
NO20005003L (no) 2000-12-06
OA11534A (en) 2004-05-06
AP2000001946A0 (en) 2000-12-31
IS5634A (is) 2000-09-22
HK1032060A1 (en) 2001-07-06
PT1070078E (pt) 2003-06-30
CN1304413A (zh) 2001-07-18
DK1070078T3 (da) 2003-05-19
GEP20022840B (en) 2002-11-25
EA002953B1 (ru) 2002-12-26
TR200002847T2 (tr) 2001-01-22
PL343712A1 (en) 2001-08-27
HUP0101549A3 (en) 2003-07-28
WO1999051617A3 (en) 1999-12-09
BRPI9909471B1 (pt) 2018-11-21
KR100573635B1 (ko) 2006-04-26
PE20000356A1 (es) 2000-04-26
EP1070078A2 (en) 2001-01-24
ES2191429T3 (es) 2003-09-01
BRPI9909471B8 (pt) 2021-05-25
JP2002510702A (ja) 2002-04-09
GB9807355D0 (en) 1998-06-03
HRP20000670A2 (en) 2000-12-31
EE200000585A (et) 2002-04-15
CN1222534C (zh) 2005-10-12
ZA200005197B (en) 2001-09-27
KR20010074473A (ko) 2001-08-04
MA26617A1 (fr) 2004-12-20
AR014973A1 (es) 2001-04-11
IL138559A (en) 2006-12-31
SK14822000A3 (sk) 2001-07-10
EG24597A (en) 2009-12-14
AU3703899A (en) 1999-10-25
CA2327495A1 (en) 1999-10-14
NZ507012A (en) 2003-06-30
EE04121B1 (et) 2003-08-15
EP1070078B1 (en) 2003-01-22
DE69905025D1 (de) 2003-02-27
HUP0101549A2 (hu) 2001-10-28
WO1999051617A2 (en) 1999-10-14
IL138559A0 (en) 2001-10-31
ID26573A (id) 2001-01-18
NO316896B1 (no) 2004-06-14
ATE231517T1 (de) 2003-02-15
PL194752B1 (pl) 2007-07-31
CO5011057A1 (es) 2001-02-28
BR9909471A (pt) 2000-12-19
SK283735B6 (sk) 2003-12-02
US6482939B1 (en) 2002-11-19
BG104909A (bg) 2001-06-29

Similar Documents

Publication Publication Date Title
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
GEP20043375B (en) APRIL-Receptor (BCMA) and Use Thereof
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
YU76100A (sh) Pirolo(2,3-d) pirimidin preparati i njihova primena
MY116478A (en) Tri-substituted imidazoles having multiple therapeutic properties
BG105830A (en) C-21 modified epothilones
HUP0303825A3 (en) 1h-benzimidazole and 3h-imidazo-[4,5b]pyridine-derivatives, their use and pharmaceutical compositions containing them
TR200100054T2 (tr) Paroksetin metansülfonat
DE69905368D1 (en) Oxydiertes thymosin beta 4
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
YU13301A (sh) Muskarinski agonisti i antagonisti
SE9802937D0 (sv) Novel compounds
YU58600A (sh) Oblik vi 5,6-dihloro-2-(izopropilamino)-1-(beta-l-ribofuranozil)-1h-benzimidazola
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
TR200200278T2 (tr) Kalsilitik bileşimler
DE69943239D1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
MD980129A (en) Antiherpetic remedy
MXPA02005649A (es) Nuevas combinaciones terapeuticas de (s)-2 -(bencilamino -metil)-2, 3, 8, 9-tetrahidro-7h -1, 4-dioxino(2-3 -e]indol-8 -ona y agentes neurolepticos para el tratamiento o prevencion de trastornos psicoticos.
ZA200201384B (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacyloalkene-2-one.
MX9804068A (es) Nuevos derivados de quinoxalindiona, su preparacion y empleo en medicamentos.
DK0980379T3 (da) Chimære oligonucleotider og deres anvendelse
UA67058A (en) Composition for treating periodontitis
RU96103721A (ru) Антгельминтное средство